30 November 2022
The CTCM team visited Eudaemon Technologies to meet with the project team to find out more about the development of an innovative new generation condom offering an alternative for sexual health and wellness.
MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program team recently met with Round One awardees for kick-off project meetings on-site at Navi Medical Technologies, Eudaemon Technologies, ARIA and LBT Innovations, and virtually with OncoRes Medical.
In Melbourne, Navi is developing the Neonav®, a device that helps guide and monitor a catheter’s position in newborns and young children, and the team’s visit included a tour of the Neonatal Intensive Care Unit at The Women's.
In Sydney, the team visited Eudaemon at its base at IDE Group headquarters, to meet with Robert Gorkin, Nick Northcott and Simon Cook for a tour of facilities. Using an advanced material, Eudaemon is developing an innovative new generation condom to disrupt the existing contraception on the market and offer an alternative for sexual health and wellness.
Next up, the CTCM team visited start-up ARIA in its new Sydney headquarters and learned about the evolution of the company and its non-invasive, nonsurgical device applicable to all forms of blindness regardless of underlying cause. The team discussed how ARIA is making a clear impact in an underserved part of the community, to people who are blind and low vision, by bringing consumers on the journey right from the start.
Heading over to South Australia, the team met with awardee LBT Innovations in Adelaide for the project kick-off meeting and to hear more about the evolution of its APAS technology, including APAS Compact technology which uses Artificial Intelligence and image analysis to automate the reading of culture plates, optimising microbiologists’ workloads and patient health outcomes.
While the kick-off meeting with OncoRes Medical was held virtually, the talented team took CTCM through its novel diagnostic imaging technology which is designed to guide surgical clearance of cancer in breast conserving surgery. The CTCM team is looking forward to an on-site visit and tour of OncoRes Medical facilities in Perth in early 2023.
Tour of Tonsley Innovation District
In Adelaide, the team also met with Dr Andrew Milligan from Medical Device Partnering Program (MDPP), Stuart Anderson from Medical Technology Association of Australia (MTAA), Hebbat Manhy from Cicada Innovations and Joel Spotswood from the BridgeTech Program to take a tour of Tonsley Innovation District with Philip Dautel the Precinct Director.
A 61-hectare site located 10km south of Adelaide, Tonsley is recognised as a benchmark for reimagining and redeveloping traditional manufacturing facilities. Tonsley includes leading-edge research and education institutions, established businesses, start-ups, business incubators and accelerators, as well as government and the wider community.
MTPConnect’s Adelaide Intermediary Program team also hosted the CTCM team for morning tea to share news, project chats and more.